Transgenic perspectives in xenotransplantation, 2001

1. HAMMER C, THEIN E. Determining significant physiologic incompatibilities. Graft 2001; 4: 108. 2. STANKOVICOVA T, SZILARD M, DE-SCHNEEBERGER I, SIPIO K. M cells and transmural heterogeneity of action potential configuration in myocytes from the left ventricular wall of the pig heart. Cardiovasc Res 2000; 45: 952. 3. KIRKMAN R. Of swine and man: organ physiology in different species. In: HARDY M, ed. Xenograft 25. Amsterdam: Elsevier Sciences, 1989: p. 125. 4. CRICK S, ONG D. Localisation and quantitation of autonomic innervation in the porcine heart. J Anat 1999; 195: 341/359. 5. BRENNER P, SCHMOECKEL M, REICHENSPURNER H et al. IG-Therasorb immunoapheresis in orthotopic xenotransplantation of baboons with landrace pig hearts. Transplantation 2000; 69: 208. 6. KALADY M, LAWSON J, SORREL R, PLATT J. Decrease fibrinolytic activity in porcine-to-primate cardiac xenotransplantation. Mol Med 1998; 4: 629. 7. CHENG D, ONG D. Anaesthesia for non-cardiac surgery in heart transplanted patients. Can J Anaesth 1993; 40: 1981. 8. MOLLEVI D, JAURRIETA E, RIBAS Y et al. Liver xenotransplantation: changes in lipid and lipoprotein concentration after long term graft survival. J Hepatol 2000; 32: 655. 9. MINGUELA A, RAMIREZ P, CARRACOSA C et al. Identification of porcine proteins in baboon sera after pig liver xenotransplantation. Transplant Proc 1999; 31: 2635. 10. MAJADO M, RAMIREZ P, MINGUELA A et al. Evolution of blood coagulation factors and hemotherapeutic support in three pig-to-baboon orthotopic liver xenotransplants. Transplant Proc 1999; 31: 2622. 11. RAMIREZ P, CHAVEZ R, MAJADO M et al. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the non-human primate for up to 8 days. Transplantation 2000; 70: 989. 12. CRUZADO J, TORRAS J, RIERA M et al. Effect of human natural antibody depletion and complement inactivation on early pig kidney function. Exp Nephrol 1999; 7: 217. 13. MARUYAMA S, CANTU E, DEMARTINO C et al. Membranous glomerulonephritis induced in the pig by antibodies to angiotensin converting enzyme. Am J Soc Nephrol 1999; 10: 2102. 14. COZZI E, BHATTI F, SCHMOECKEL M et al. Long term survival of non-human primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70: 15. 15. PRZEMEK M, VANGEROW B, LOSS M et al. Hemodynamic consequences of porcine kidney xenograft reperfusion in cynomolgus monkeys. Transplantation 2001; 71: 1512. 16. BENNET W, SUNDBERG B, LUNDGREN T et al. Damage of porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomolgus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711. 17. DAGETT C, YEATMAN M, LODGE A et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 1998; 115: 19. 18. KAPLON R, PLATT J, KWIATKOWSKI P et al. Absence of hyperacute rejection in pig to primate orthotopic xenografts. Transplantation 1995; 59: 410. 19. DAGGETT C, YEATMAN M, LODGE A et al. Swine lungs expressing human complement-regulatory proteins. J Thorac Cardiovasc Surg 1997; 113: 390. 20. YEATMAN M, DAGGETT C, LAU C et al. Human complement regulatory proteins protect swine lungs from xenogeneic Injury. Ann Thorac Surg 1999; 67: 769. 21. SCHELZIG H, SIMON F, KRISCHER C et al. Ex-vivo hemoperfusion (eHPS) of pig lungs with whole human blood: effect of complement inhibitor with a soluble C1-esterase inhibitor. Ann Transplant 2001; 6: 34. 22. HAMMER C. In vivo microscopic assessment of microcirculatory changes in a concordant xenogeneic primate experimental set-up. Ann Transplant 2001; 6: 17. 23. HAMMER C, WAGNER F, THEIN E. Microvasculature after xenografting. Curr Opin Organ Transpl 2001; 6: 47. 24. THEIN E, SEVILMIS G, MüENZING S et al. Evaluation of a system for the perfusion of isolated, rodent organs. Xenotransplantation 2001; 8: 94. 25. ALVAREZ B, DOMENECH N, ALONSO F et al. Molecular and functional characterisation of porcine LFA-1 using monoclonal antibodies to CD 11a and CD 18. Xenotransplantation 2000; 7: 258. 26. TERAJIMA H, THIAENER A, HAMMER C et al. Attenuation of hepatic microcirculatory failure during in situ xenogeneic rat liver perfusion by heat shock preconditioning. Transplant Proc 2000; 32: 1111. 27. ROBSON S, COOPER D, D’APICE A. Disordered regulation and platelet activation in xenotransplantation. Xenotransplantation 2000; 7: 166. 28. ALWAYN I, ROBSON S. Understanding and preventing the coagulation disorders associated with xenograft rejection. Graft 2000; 4: 50.

[1]  A. Robins,et al.  Effect of DNA concentration on transgenesis rates in mice and pigs , 2001, Transgenic Research.

[2]  D. Adams,et al.  Anaesthetic Management of Baboons Undergoing Heterotopic Porcine Cardiac Xenotransplantation , 2001, Veterinary Research Communications.

[3]  Yifan Dai,et al.  Targeted disruption of the α1,3-galactosyltransferase gene in cloned pigs , 2002, Nature Biotechnology.

[4]  Kwang-Wook Park,et al.  Production of α-1,3-Galactosyltransferase Knockout Pigs by Nuclear Transfer Cloning , 2002, Science.

[5]  H. Hauser,et al.  CYTOMEGALOVIRUS EARLY PROMOTER INDUCED EXPRESSION OF hCD59 IN PORCINE ORGANS PROVIDES PROTECTION AGAINST HYPERACUTE REJECTION1 , 2001, Transplantation.

[6]  X. M. Fernández-Suárez,et al.  In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. , 2001, Transplantation.

[7]  R. Colvin,et al.  Pig kidney transplantation in baboons: anti-Gal(alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. , 2001, Transplantation.

[8]  A. D'apice,et al.  Genetic modification for xenotransplantation: transgenics and clones. , 2001, Transplantation proceedings.

[9]  T. Shigehisa,et al.  Remodeling of the Major Pig Xenoantigen by N-Acetylglucosaminyltransferase III in Transgenic Pig* , 2001, The Journal of Biological Chemistry.

[10]  W. Li,et al.  Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. , 2001, FEMS immunology and medical microbiology.

[11]  B. Soin,et al.  Physiological aspects of pig-to-primate renal xenotransplantation. , 2001, Kidney international.

[12]  A. Bradbury,et al.  Using an in vivo phagemid system to identify non‐compatible loxP sequences , 2001, FEBS letters.

[13]  M. Brendel,et al.  EXPRESSION OF COMPLEMENT REGULATORY PROTEINS ON ISLETS OF LANGERHANS: A COMPARISON BETWEEN HUMAN ISLETS AND ISLETS ISOLATED FROM NORMAL AND hDAF TRANSGENIC PIGS1 , 2001, Transplantation.

[14]  J. Klempnauer,et al.  HEMODYNAMIC CONSEQUENCES OF PORCINE KIDNEY XENOGRAFT REPERFUSION IN CYNOMOLGUS MONKEYS1,2 , 2001, Transplantation.

[15]  Angelika Berg,et al.  Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental
and clinical xenotransplantation , 2001, Xenotransplantation.

[16]  K. Messmer,et al.  Evaluation of a system for the perfusion of isolated, rodent organs , 2001, Xenotransplantation.

[17]  D. Adams,et al.  Transgenic porcine valves show no signs of delayed cardiac xenograft rejection. , 2001, The Annals of thoracic surgery.

[18]  C. Carrington,et al.  Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition , 2001, Xenotransplantation.

[19]  W. Heneine,et al.  LACK OF CROSS-SPECIES TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUS INFECTION TO NONHUMAN PRIMATE RECIPIENTS OF PORCINE CELLS, TISSUES, OR ORGANS1 , 2001, Transplantation.

[20]  K. Boller,et al.  Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. , 2001, The Journal of general virology.

[21]  F. Wagner,et al.  Microvasculature after xenografting , 2001 .

[22]  D. Adams,et al.  Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates , 2001, Xenotransplantation.

[23]  R. Mañez,et al.  Removal of bowel aerobic gram‐negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural α‐Galactosyl IgG antibodies , 2001, Xenotransplantation.

[24]  J. Platt,et al.  A HUMAN CD46 TRANSGENIC PIG MODEL SYSTEM FOR THE STUDY OF DISCORDANT XENOTRANSPLANTATION , 2001, Transplantation.

[25]  R. Wall,et al.  Pronuclear microinjection. , 2001, Cloning and stem cells.

[26]  R. Alberio,et al.  Nuclear transfer in practice. , 2001, Cloning and stem cells.

[27]  C. Hammer.  In vivo microscopic assessment of microcirculatory changes in a concordant xenogeneic primate experimental set up. , 2001, Annals of transplantation.

[28]  S. Robson,et al.  Understanding and Preventing the Coagulation Disorders Associated with Xenograft Rejection , 2001 .

[29]  J. Fletcher,et al.  Gene targeting in primary fetal fibroblasts from sheep and pig. , 2001, Cloning and stem cells.

[30]  M. Pfister-Genskow,et al.  Production of cloned pigs from in vitro systems , 2000, Nature Biotechnology.

[31]  Yifan Dai,et al.  Cloned pigs produced by nuclear transfer from adult somatic cells , 2000, Nature.

[32]  A Onishi,et al.  Pig cloning by microinjection of fetal fibroblast nuclei. , 2000, Science.

[33]  A. B. Stewart,et al.  Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. , 2000, Transplantation.

[34]  B. Sauer.  Inducible gene targeting in mice using the Cre/lox system. , 1998, Methods.

[35]  I. Wilmut,et al.  "Viable Offspring Derived from Fetal and Adult Mammalian Cells" (1997), by Ian Wilmut et al. , 2014 .

[36]  P. Verma,et al.  Developments in transgenic techniques in pigs. , 1997, Journal of reproduction and fertility. Supplement.

[37]  M. Katsuki,et al.  Humanized prion protein knock-in by Cre-induced site-specific recombination in the mouse. , 1996, Biochemical and biophysical research communications.